PUT/NOVO-NORDISK B/1400/0.1/21.06.24 | Real-time BOERSE MUENCHEN 02:26:30 2024-05-22 pm EDT | ||
| 6.43 EUR | 0.00% |
|
| Current month | -3.31% | ||
| 1 month | -11.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 6.43 | 0.00% |
| 24-05-21 | 6.43 | -3.45% |
| 24-05-20 | 6.66 | -0.30% |
| 24-05-17 | 6.68 | +1.52% |
| 24-05-16 | 6.58 | +0.77% |
Real-time BOERSE MUENCHEN
Last update May 22, 2024 at 02:26 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | Goldman Sachs |
| WKN | GQ4VDQ |
| ISIN | DE000GQ4VDQ1 |
| Date issued | 2023-09-13 |
| Strike | 1,400 kr |
| Maturity | 2024-06-21 (30 Days) |
| Parity | 10 : 1 |
| Emission price | 9.63 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.47 € |
|---|---|
| Lowest since issue | 6.33 € |
| Spread | 0.1 € |
| Spread % | 1.53% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
927.2
DKK
Average target price
909.2
DKK
Spread / Average Target
-1.94%
- Stock Market
- Warrants
- Warrant
